5-ethynyl-1-ribofuranosylimidazole-4-carboxamide has been researched along with guanosine triphosphate in 5 studies
Studies (5-ethynyl-1-ribofuranosylimidazole-4-carboxamide) | Trials (5-ethynyl-1-ribofuranosylimidazole-4-carboxamide) | Recent Studies (post-2010) (5-ethynyl-1-ribofuranosylimidazole-4-carboxamide) | Studies (guanosine triphosphate) | Trials (guanosine triphosphate) | Recent Studies (post-2010) (guanosine triphosphate) |
---|---|---|---|---|---|
21 | 0 | 2 | 14,728 | 25 | 2,115 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balzarini, J; De Clercq, E | 1 |
Balzarini, J; De Clercq, E; Lee, CK; Schols, D | 1 |
Balzarini, J; Bohman, C; De Clercq, E; Fridland, A; Herdewijn, P; Horská, K; Karlsson, A; Van Aerschot, A; Votruba, I; Wang, L | 1 |
Balzarini, J; De Clercq, E; Leyssen, P; Neyts, J | 1 |
Günther, S; Neyts, J; Ölschläger, S | 1 |
5 other study(ies) available for 5-ethynyl-1-ribofuranosylimidazole-4-carboxamide and guanosine triphosphate
Article | Year |
---|---|
Assay method for monitoring the inhibitory effects of antimetabolites on the activity of inosinate dehydrogenase in intact human CEM lymphocytes.
Topics: Adenosine Triphosphate; Antimetabolites; Cell Line; Guanosine Triphosphate; Humans; Hypoxanthine; Hypoxanthines; IMP Dehydrogenase; Inosine; Inosine Monophosphate; Kinetics; Lymphocytes; Ribonucleosides | 1992 |
1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymph
Topics: Antiviral Agents; Cells, Cultured; Didanosine; Drug Synergism; Guanosine Diphosphate; Guanosine Monophosphate; Guanosine Triphosphate; HIV-1; Humans; Inosine Monophosphate; Kinetics; Lymphocytes; Ribavirin; Ribonucleosides | 1991 |
Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.
Topics: Adenosine; Animals; Antineoplastic Agents; Cell Division; Deoxyguanine Nucleotides; Guanine; Guanosine; Guanosine Triphosphate; Humans; IMP Dehydrogenase; Leukemia L1210; Lymphocytes; Mice; Mycophenolic Acid; Purine Nucleotides; Ribavirin; Ribonucleosides; Ribonucleotides; Tumor Cells, Cultured | 1993 |
The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Guanosine Triphosphate; IMP Dehydrogenase; Microbial Sensitivity Tests; Mycophenolic Acid; Parainfluenza Virus 3, Human; Ribavirin; Ribonucleosides; Vero Cells; Virus Replication; Yellow fever virus | 2005 |
Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Ebolavirus; Guanosine; Guanosine Triphosphate; IMP Dehydrogenase; Lassa virus; Mycophenolic Acid; Ribavirin; Ribonucleosides; Vero Cells; Virus Replication | 2011 |